Pain Management of ACL Reconstruction

Part of paid clinical trials in Sacramento, California.

Sponsor
University of California, Davis
Study ID
NCT03365908
Status
Enrolling By Invitation

Conditions

  • Anterior Cruciate Ligament Rupture

Eligibility Criteria

Sex
ALL
Age
18 Years - 45 Years
Healthy Volunteers
Not accepted

Interventions

  • Adductor Canal Nerve Block — PROCEDURE
    An adductor canal nerve block with 15 mL of 0.5% ropivacaine will be performed pre-operatively by Anesthesiology.
  • Ropivacaine injection — DRUG
    15 mL of 0.5% ropivacaine will be administered for the adductor canal block

Study Details

This study will compare the outcome of pain interventions that are considered standard of care during the surgical treatment of ACL injuries. The comparison will be looking at pain control during and after ACL surgery as well as functional outcomes in patients that had a nerve block versus those who did not. The investigators hypothesize that pain control will be equal between both groups.

Key Dates

Start date
Oct 9, 2017
Status verified
Nov 2025
Primary completion
Jul 1, 2026
Completion
Jul 1, 2026

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Adductor Canal Nerve Block
    Participant will receive an adductor canal nerve block via 15 mL 0.5% ropivacaine injection prior to OR for ACL reconstruction. Participant will receive pre-op oral medications.
  • No Intervention: No Nerve Block
    Participant will receive pre-op oral medications but no nerve block prior to OR for ACL reconstruction.

Primary Outcome Measure

Immediate Post-op Pain Score [ Time Frame: 15 min post-op ]

Locations (1)

FacilityCityStateZIPSite coordinators
UC Davis HealthSacramentoCalifornia95817-

Find similar trials in Sacramento, CA

By research site
UC Davis Health· Sacramento, CA

Related Studies